Search Results - "Klostergaard, Jim"
-
1
Combinatorial Selection of DNA Thioaptamers Targeted to the HA Binding Domain of Human CD44
Published in Biochemistry (Easton) (26-10-2010)“…CD44, the primary receptor for hyaluronic acid, plays an important role in tumor growth and metastasis. CD44−hyaluronic acid interactions can be exploited for…”
Get full text
Journal Article -
2
Hyaluronic Acid- Paclitaxel: Antitumor Efficacy against CD44(+) Human Ovarian Carcinoma Xenografts
Published in Neoplasia (New York, N.Y.) (01-06-2007)“…Numerous human tumor types, including ovarian cancer, display a significant expression of the CD44 family of cell surface proteoglycans. To develop…”
Get full text
Journal Article -
3
Magnetic resonance imaging contrast enhancement in vitro and in vivo by octanuclear iron-oxo cluster-based agents
Published in Journal of inorganic biochemistry (01-09-2018)“…A water-soluble octanuclear cluster, [Fe8], was studied with regard to its properties as a potential contrast enhancing agent in magnetic resonance imaging…”
Get full text
Journal Article -
4
Drug-tolerant cancer cells show reduced tumor-initiating capacity: depletion of CD44 cells and evidence for epigenetic mechanisms
Published in PloS one (15-09-2011)“…Cancer stem cells (CSCs) possess high tumor-initiating capacity and have been reported to be resistant to therapeutics. Vice versa, therapy-resistant cancer…”
Get full text
Journal Article -
5
Antitumor Activity of Hydrophilic Paclitaxel Copolymer Prodrug Using Locoregional Delivery in Human Orthotopic Non–Small Cell Lung Cancer Xenograft Models
Published in Clinical cancer research (01-11-2004)“…Paclitaxel (Taxol) has demonstrated clinical activity in non–small-cell lung cancer (NSCLC), but its use has not led to marked improvements in survival. This…”
Get full text
Journal Article -
6
Superior Therapeutic Profile of Poly-l-Glutamic Acid-Paclitaxel Copolymer Compared with Taxol in Xenogeneic Compartmental Models of Human Ovarian Carcinoma
Published in Clinical cancer research (01-02-2002)“…Previous preclinical studies with ectopic tumor models have demonstrated remarkable improvements in the therapeutic profile of paclitaxel, formulated as a…”
Get full text
Journal Article -
7
BRAF Mutations as Actionable Targets: A Paradigm Shift in the Management of Colorectal Cancer and Novel Avenues
Published in JCO oncology practice (01-12-2021)“…mutations in colorectal cancer have been studied over the past several decades. V600E mutation, a class I mutation, is the most common oncogenic alteration in…”
Get more information
Journal Article -
8
Precision medicine for metastatic colorectal cancer: an evolving era
Published in Expert review of gastroenterology & hepatology (03-10-2019)“…: Metastatic colorectal cancer (CRC) remains a dilemma for cancer researchers with an increasing incidence in the younger patient population. Until the last…”
Get more information
Journal Article -
9
Transmembrane TNF (pro-TNF) is palmitoylated
Published in FEBS letters (29-06-2001)“…Human transmembrane tumor necrosis factor (pro-TNF) was examined for protein acylation. The cDNA encoding pro-TNF was expressed in both COS-1 cells and Sf9…”
Get full text
Journal Article -
10
Magnetic nanovectors for drug delivery
Published in Nanomedicine (01-09-2012)“…Abstract Nanotechnology holds the promise of novel and more effective treatments for vexing human health issues. Among these are the use of nanoparticle…”
Get full text
Journal Article -
11
CD44: a validated target for improved delivery of cancer therapeutics
Published in Expert opinion on therapeutic targets (01-07-2012)“…Advances in cancer therapeutics, namely more effective and less toxic treatments, will occur with targeting strategies that enhance the tumor biodistribution…”
Get more information
Journal Article -
12
CD44 as a drug delivery target in human cancers: where are we now?
Published in Expert opinion on therapeutic targets (02-12-2015)“…In the treatment of cancers, the dual goals of drug targeting are to deliver therapeutic agents more selectively to tumor tissue and to minimize exposure of…”
Get more information
Journal Article -
13
Magnetic nanovectors for drug delivery
Published in Maturitas (01-09-2012)“…Abstract Nanotechnology holds the promise of novel and more effective treatments for vexing human health issues. Among these are the use of nanoparticle…”
Get full text
Journal Article -
14
Targeting SH2 domains in breast cancer
Published in Future medicinal chemistry (01-01-2014)“…Breast cancer is among the most commonly diagnosed cancer types in women worldwide and is the second leading cause of cancer-related disease in the USA. SH2…”
Get more information
Journal Article -
15
TRIB2 contributes to cisplatin resistance in small cell lung cancer
Published in Oncotarget (12-12-2017)“…Small cell lung cancer (SCLC) is the most aggressive lung-cancer subtype and so far, no favorable therapeutic strategy has been established for chemo-resistant…”
Get full text
Journal Article -
16
Magnetic nanovectors for drug delivery: Nanotechnology: From Fundamental Concepts to Clinical Applications for Healthy Aging
Published in Maturitas (2012)Get full text
Journal Article -
17
Human pro-tumor necrosis factor: molecular determinants of membrane translocation, sorting, and maturation
Published in Molecular and Cellular Biology (01-11-1995)“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
18
A Part of the Transmembrane Domain of pro-TNF Can Function as a Cleavable Signal Sequence That Generates a Biologically Active Secretory Form of TNF
Published in Journal of biochemistry (Tokyo) (01-08-1999)“…To determine the minimum requirement in the 76-residue leader sequence of pro-tumor necrosis factor (TNF) for membrane translocation across the endoplasmic…”
Get full text
Journal Article -
19
Hyaluronic acid–paclitaxel conjugate inhibits growth of human squamous cell carcinomas of the head and neck via a hyaluronic acid-mediated mechanism
Published in Oral oncology (01-11-2011)“…Summary Chemotherapeutic regimens incorporating taxanes significantly improve outcomes for patients with squamous cell carcinomas of the head and neck (SCCHN)…”
Get full text
Journal Article -
20
Magnetically vectored platforms for the targeted delivery of therapeutics to tumors: history and current status
Published in Nanomedicine (London, England) (01-02-2012)“…Superparamagnetic iron oxide nanoparticles (SPIONs) are being developed as vehicles for the selective targeting of therapeutics and bioactive compounds…”
Get more information
Journal Article